Synergy of a hepatitis C virus (HCV) NS4A antagonist in combination with HCV protease and polymerase inhibitors.
Antimicrobial agents and chemotherapy • Vol. 52, Issue 5 • 2008
Ultra-rapid cardiotoxicity of the hepatitis C virus protease inhibitor BILN 2061 in the urokinase-type plasminogen activator mouse.
Gastroenterology • Vol. 133, Issue 4 • 2007
Phenylglycine as a novel P2 scaffold in hepatitis C virus NS3 protease inhibitors.
Bioorganic & medicinal chemistry • Vol. 15, Issue 3 • 2007
Potent inhibitors of the hepatitis C virus NS3 protease: use of a novel P2 cyclopentane-derived template.
Bioorganic & medicinal chemistry • Vol. 14, Issue 15 • 2006